Carotid stenting versus endarterectomy in patients undergoing reintervention after prior carotid endarterectomy.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3852203)

Published in J Vasc Surg on August 22, 2013

Authors

Margriet Fokkema1, Gert Jan de Borst2, Brian W Nolan3, Ruby C Lo1, Robert A Cambria4, Richard J Powell3, Frans L Moll2, Marc L Schermerhorn5, Vascular Study Group of New England

Author Affiliations

1: Department of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, Mass.
2: Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
3: Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
4: Department of Vascular Surgery, Eastern Maine Medical Center, Bangor, Me.
5: Department of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, Mass. Electronic address: mscherme@bidmc.harvard.edu.

Articles citing this

Carotid revascularization: risks and benefits. Vasc Health Risk Manag (2014) 0.87

Clinical relevance of cranial nerve injury following carotid endarterectomy. Eur J Vasc Endovasc Surg (2013) 0.86

Carotid Endarterectomy: Current Concepts and Practice Patterns. Int J Angiol (2015) 0.75

Articles cited by this

Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med (2004) 12.58

Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med (2008) 4.72

Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol (2012) 3.11

A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE). J Vasc Surg (2007) 2.96

Factors associated with stroke or death after carotid endarterectomy in Northern New England. J Vasc Surg (2008) 2.22

Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: implications for selecting patients for carotid angioplasty and stenting. J Vasc Surg (2004) 1.82

Carotid artery stenting-induced hemodynamic instability. J Endovasc Ther (2013) 1.62

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. J Am Coll Cardiol (2011) 1.61

Carotid artery stenting: analysis of data for 105 patients at high risk. J Vasc Surg (2003) 1.53

Duplex ultrasound velocity criteria for the stented carotid artery. J Vasc Surg (2008) 1.43

Restenosis after carotid endarterectomy and stenting. Lancet Neurol (2012) 1.08

Recurrent carotid stenosis. A five-year series of 65 reoperations. Ann Surg (1985) 1.07

Restenosis after carotid endarterectomy in a multicenter regional registry. J Vasc Surg (2010) 1.06

Comparison of carotid endarterectomy and stenting in real world practice using a regional quality improvement registry. J Vasc Surg (2012) 0.98

High-risk carotid endarterectomy: fact or fiction. J Vasc Surg (2003) 0.94

Histological characterization of restenotic carotid plaques in relation to recurrence interval and clinical presentation: a cohort study. Stroke (2008) 0.93

Cranial and cervical nerve injuries after repeat carotid endarterectomy. J Vasc Surg (2000) 0.90

Reoperation for recurrent carotid stenosis: early results and late outcome in 199 patients. J Vasc Surg (2001) 0.88

Carotid restenosis: operative and endovascular management. J Vasc Surg (1999) 0.86

Recurrent carotid stenosis after CEA and CAS: diagnosis and management. Semin Vasc Surg (2007) 0.85

Natural history of recurrent and residual stenosis after carotid endarterectomy: implications for postoperative surveillance and surgical management. Surgery (1992) 0.85

Treatment of recurrent cerebrovascular disease. Review of a 10-year experience. Ann Surg (1995) 0.85

Reoperation for carotid stenosis is as safe as primary carotid endarterectomy. J Vasc Surg (1999) 0.85

Primary carotid artery stenting versus carotid artery stenting for postcarotid endarterectomy stenosis. J Vasc Surg (2009) 0.84

Recurrent stenosis and contralateral occlusion: high-risk situations in carotid endarterectomy? Ann Vasc Surg (2003) 0.84

The impact of Centers for Medicare and Medicaid Services high-risk criteria on outcome after carotid endarterectomy and carotid artery stenting in the SVS Vascular Registry. J Vasc Surg (2013) 0.83

Carotid artery stenting outcomes are equivalent to carotid endarterectomy outcomes for patients with post-carotid endarterectomy stenosis. J Vasc Surg (2010) 0.83

Society of vascular surgery vascular registry comparison of carotid artery stenting outcomes for atherosclerotic vs nonatherosclerotic carotid artery disease. J Vasc Surg (2010) 0.82

Management of recurrent carotid stenosis: should asymptomatic lesions be treated surgically? J Vasc Surg (1996) 0.82

Durability of surgery for restenosis after carotid endarterectomy. J Vasc Surg (2007) 0.81

Poor durability of carotid angioplasty and stenting for treatment of recurrent artery stenosis after carotid endarterectomy: an institutional experience. J Vasc Surg (2001) 0.79

Redo surgery or carotid stenting for restenosis after carotid endarterectomy: results of two different treatment strategies. Ann Vasc Surg (2009) 0.78

Comparative study of operative treatment and percutaneous transluminal angioplasty/stenting for recurrent carotid disease. J Vasc Surg (2001) 0.78

Redo carotid endarterectomy versus primary carotid endarterectomy. Stroke (2001) 0.78

Surgical treatment of recurrent carotid artery stenosis. J Neurosurg (1994) 0.78

Safety and durability of redo carotid operation: an 11-year experience. J Vasc Surg (2004) 0.78

Safety and efficacy of reoperative carotid endarterectomy: a 14-year experience. J Vasc Surg (2005) 0.77

Open surgery remains a valid option for the treatment of recurrent carotid stenosis. J Vasc Surg (2010) 0.77

Restenosis after carotid surgery: the importance of clinical presentation and preoperative timing. Stroke (2011) 0.77

Redo carotid surgery: An analysis of materials and configurations used in carotid reoperations and their influence on perioperative stroke and subsequent recurrent stenosis. J Vasc Surg (1999) 0.76

Articles by these authors

The effect of postoperative myocardial ischemia on long-term survival after vascular surgery. J Vasc Surg (2013) 2.72

Optimal selection of asymptomatic patients for carotid endarterectomy based on predicted 5-year survival. J Vasc Surg (2013) 2.16

Intraoperative use of dextran is associated with cardiac complications after carotid endarterectomy. J Vasc Surg (2013) 2.02

Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery. J Vasc Surg (2014) 1.77

A regional quality improvement effort to increase beta blocker administration before vascular surgery. J Vasc Surg (2011) 1.61

The financial implications of endovascular aneurysm repair in the cost containment era. J Vasc Surg (2013) 1.57

Outcomes and practice patterns in patients undergoing lower extremity bypass. J Vasc Surg (2012) 1.53

Impact of practice patterns in shunt use during carotid endarterectomy with contralateral carotid occlusion. J Vasc Surg (2011) 1.53

The need for treatment of hemodynamic instability following carotid endarterectomy is associated with increased perioperative and 1-year morbidity and mortality. J Vasc Surg (2013) 1.42

The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg (2010) 1.34

Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice. J Vasc Surg (2011) 1.16

National trends in utilization, mortality, and survival after repair of type B aortic dissection in the Medicare population. J Vasc Surg (2014) 1.14

Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass. J Vasc Surg (2011) 1.13

Optimal selection of patients for elective abdominal aortic aneurysm repair based on life expectancy. J Vasc Surg (2013) 0.99

Comparison of carotid endarterectomy and stenting in real world practice using a regional quality improvement registry. J Vasc Surg (2012) 0.98

Predicting functional status following amputation after lower extremity bypass. Ann Vasc Surg (2012) 0.95

Variation in smoking cessation after vascular operations. J Vasc Surg (2013) 0.92

Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery. J Vasc Surg (2011) 0.92

Shared quality data are associated with increased protamine use and reduced bleeding complications after carotid endarterectomy in the Vascular Study Group of New England. J Vasc Surg (2013) 0.91

Blood transfusion for lower extremity bypass is associated with increased wound infection and graft thrombosis. J Am Coll Surg (2013) 0.90

Growing impact of restenosis on the surgical treatment of peripheral arterial disease. J Am Heart Assoc (2013) 0.89

Routine use of ultrasound guidance in femoral arterial access for peripheral vascular intervention decreases groin hematoma rates. J Vasc Surg (2015) 0.88

Critical Limb Ischemia: Current Trends and Future Directions. J Am Heart Assoc (2016) 0.87

Clinical relevance of cranial nerve injury following carotid endarterectomy. Eur J Vasc Endovasc Surg (2013) 0.86

Contemporary Management Strategies for Chronic Type B Aortic Dissections: A Systematic Review. PLoS One (2016) 0.86

Predictors of aortic growth in uncomplicated type B aortic dissection. J Vasc Surg (2014) 0.84

Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia. Ann Vasc Surg (2013) 0.84

Cilostazol is associated with improved outcomes after peripheral endovascular interventions. J Vasc Surg (2014) 0.82

Outcomes of lower extremity bypass performed for acute limb ischemia. J Vasc Surg (2013) 0.82

Results of endovascular repair of infrarenal aortic aneurysms using the Endurant stent graft. J Vasc Surg (2014) 0.82

Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival. J Vasc Surg (2014) 0.81

Risk factors and consequences of persistent type II endoleaks. J Vasc Surg (2016) 0.80

Percutaneous versus femoral cutdown access for endovascular aneurysm repair. J Vasc Surg (2015) 0.80

Preventive measures for patients at risk for amputation from diabetes and peripheral arterial disease. Diabetes Care (2014) 0.80

Circulating immunoglobulins are not associated with intraplaque mast cell number and other vulnerable plaque characteristics in patients with carotid artery stenosis. PLoS One (2014) 0.80

SlideToolkit: an assistive toolset for the histological quantification of whole slide images. PLoS One (2014) 0.79

Comparison of a Vascular Study Group of New England risk prediction model with established risk prediction models of in-hospital mortality after elective abdominal aortic aneurysm repair. J Vasc Surg (2015) 0.79

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease. Cardiovasc Diabetol (2016) 0.79

Management and outcomes of isolated renal artery aneurysms in the endovascular era. J Vasc Surg (2015) 0.78

Determinants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia. J Vasc Surg (2015) 0.78

Severity of chronic obstructive pulmonary disease is associated with adverse outcomes in patients undergoing elective abdominal aortic aneurysm repair. J Vasc Surg (2013) 0.78

Type 2 diabetes is not associated with an altered plaque phenotype among patients undergoing carotid revascularization. A histological analysis of 1455 carotid plaques. Atherosclerosis (2014) 0.77

The effect of endovascular treatment on isolated iliac artery aneurysm treatment and mortality. J Vasc Surg (2015) 0.77

Leukotriene B4 levels in human atherosclerotic plaques and abdominal aortic aneurysms. PLoS One (2014) 0.76

Incidence of and risk factors for bowel ischemia after abdominal aortic aneurysm repair. J Vasc Surg (2016) 0.76

Results of transcaval embolization for sac expansion from type II endoleaks after endovascular aneurysm repair. J Vasc Surg (2015) 0.76

Prevalence and risk of cardiovascular risk factors and events in offspring of patients at high vascular risk and effect of location of parental vascular disease. Int J Cardiol (2015) 0.76

Routine use of completion imaging after infrainguinal bypass is not associated with higher bypass graft patency. J Vasc Surg (2014) 0.76

The relation between the presence of cardiovascular disease and vascular risk factors in offspring and the occurrence of new vascular events in their parents already at high vascular risk. Am Heart J (2015) 0.76

The influence of gender on functional outcomes of lower extremity bypass. J Vasc Surg (2014) 0.75

Dual antiplatelet therapy reduces stroke but increases bleeding at the time of carotid endarterectomy. J Vasc Surg (2016) 0.75

Prior contralateral amputation predicts worse outcomes for lower extremity bypasses performed in the intact limb. J Vasc Surg (2012) 0.75

Contemporary Role of Computational Analysis in Endovascular Treatment for Thoracic Aortic Disease. Aorta (Stamford) (2013) 0.75

The perioperative effect of concomitant procedures during open infrarenal abdominal aortic aneurysm repair. J Vasc Surg (2016) 0.75

Outcomes of infrainguinal bypass determined by age in the Vascular Study Group of New England. J Vasc Surg (2015) 0.75

Characteristics that define high risk in carotid endarterectomy from the Vascular Study Group of New England. J Vasc Surg (2015) 0.75

Misinterpretation of ischaemic infarct location in relationship to the cerebrovascular territories. J Neurol Neurosurg Psychiatry (2016) 0.75

Outcomes of carotid endarterectomy versus stenting in comparable medical risk patients. J Vasc Surg (2014) 0.75

Endovascular aneurysm repair delivery redesign leads to quality improvement and cost reduction. J Vasc Surg (2015) 0.75

Outcomes of lower extremity revascularization among the hemodialysis-dependent. J Vasc Surg (2015) 0.75

Lower Platelet Reactivity Is Associated with Presentation of Unstable Coronary Artery Disease. Int J Angiol (2016) 0.75

The impact of concomitant procedures during endovascular abdominal aortic aneurysm repair on perioperative outcomes. J Vasc Surg (2016) 0.75

Early extubation reduces respiratory complications and hospital length of stay following repair of abdominal aortic aneurysms. J Vasc Surg (2016) 0.75

Popliteal artery aneurysms differ from abdominal aortic aneurysms in cellular topography and inflammatory markers. J Vasc Surg (2014) 0.75

The impact of contralateral carotid artery stenosis on outcomes after carotid endarterectomy. J Vasc Surg (2017) 0.75

Preserved distal flow in a proximally occluded internal carotid artery due to a persistent proatlantal artery. J Vasc Surg (2014) 0.75

Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy. J Vasc Surg (2015) 0.75

Early carotid endarterectomy performed 2 to 5 days after the onset of neurologic symptoms leads to comparable results to carotid endarterectomy performed at later time points. J Vasc Surg (2017) 0.75

Long-Term Outcomes of Catheter-Directed Thrombolysis for Acute Lower Extremity Occlusions of Native Arteries and Prosthetic Bypass Grafts. Ann Vasc Surg (2015) 0.75

Current status and future perspectives of bioresorbable stents in peripheral arterial disease. J Vasc Surg (2016) 0.75

Endovascular treatment of complex abdominal and thoracoabdominal type IV aortic aneurysms with fenestrated technology. J Cardiovasc Surg (Torino) (2016) 0.75

The impact of female sex on long-term survival of patients with severe atherosclerosis undergoing endarterectomy. Atherosclerosis (2014) 0.75

Perioperative and long-term impact of chronic kidney disease on carotid artery interventions. J Vasc Surg (2016) 0.75

Impact of Left Subclavian Artery Revascularization Prior to Thoracic Endovascular Aortic Repair on Post-Operative Cerebrovascular Hemodynamics. Ann Vasc Surg (2017) 0.75

Reimbursement in hospital-based vascular surgery: Physician and practice perspective. J Vasc Surg (2017) 0.75

Patients with diabetes differ in atherosclerotic plaque characteristics and have worse clinical outcome after iliofemoral endarterectomy compared with patients without diabetes. J Vasc Surg (2016) 0.75

Posterior transverse plication of the internal carotid artery to correct for kinking. J Vasc Surg (2014) 0.75

Time-dependent differences in femoral artery plaque characteristics of peripheral arterial disease patients. Atherosclerosis (2016) 0.75

Association between gender and outcomes of lower extremity peripheral vascular interventions. J Vasc Surg (2015) 0.75

Shifting abdominal aortic aneurysm mortality trends in The Netherlands. J Vasc Surg (2015) 0.75

Atherosclerotic plaque characteristics are not associated with future cardiovascular events in patients undergoing iliofemoral endarterectomy. J Vasc Surg (2017) 0.75

Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical atherosclerosis. Int J Cardiol (2017) 0.75

Physical Activity and Characteristics of the Carotid Artery Wall in High-Risk Patients-The SMART (Second Manifestations of Arterial Disease) Study. J Am Heart Assoc (2017) 0.75

Core diameter of bone marrow aspiration devices influences cell density of bone marrow aspirate in patients with severe peripheral artery disease. Cytotherapy (2015) 0.75

Plasma fibrinogen level as a potential predictor of hemorrhagic complications after catheter-directed thrombolysis for peripheral arterial occlusions. J Vasc Surg (2017) 0.75

Renal complications after EVAR with suprarenal versus infrarenal fixation among all users and routine users. Eur J Vasc Endovasc Surg (2017) 0.75

Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease. Am J Cardiol (2016) 0.75

A lipid-poor plaque and asymptomatic status in women are associated with higher peak systolic velocity on duplex ultrasound after carotid endarterectomy. Atherosclerosis (2014) 0.75

Preoperative infra- and suprarenal aortic pulsatile distension is comparable between relatively young and older patients with an abdominal aortic aneurysm. Ann Vasc Surg (2013) 0.75

Stent Graft Deployment Increases Aortic Stiffness in an Ex-vivo Porcine Model. Ann Vasc Surg (2017) 0.75

A geometric reappraisal of proximal landing zones for thoracic endovascular aortic repair according to aortic arch types. J Vasc Surg (2017) 0.75

A national survey of disease-specific knowledge in patients with an abdominal aortic aneurysm. J Vasc Surg (2016) 0.75

Aneurysm sac expansion is independently associated with late mortality in patients treated with endovascular aneurysm repair. J Vasc Surg (2017) 0.75

Comparison of outcomes after endovascular and open repair of abdominal aortic aneurysms in low-risk patients. Br J Surg (2016) 0.75

Determinants of Follow-up Failure in Patients Undergoing Vascular Surgery Procedures. Ann Vasc Surg (2016) 0.75

A potential role for glycated cross-links in abdominal aortic aneurysm disease. J Vasc Surg (2016) 0.75